MONOCYTE-CHEMOATTRACTANT PROTEIN-1 LEVELS IN HUMAN ATHEROSCLEROTIC LESIONS ASSOCIATE WITH PLAQUE VULNERABILITY ArticleDichgans M., Georgakis M.K., Asare Y., Van Der Laan S.W., De Jager S.C.A., Mekke J.M., De Kleijn D.P.V., De Borst G.J., Haitjema S., Schoneveld A.H., Pasterkamp G., Nurmohamed N.S., Stroes E.S.G., Kroon J., Maegdefessel L., Soehnlein O.Arteriosclerosis, Thrombosis, and Vascular Biology. 2021. С. 2038-2048
LETTER TO THE EDITOR: RESPONSE BY WAISSI ET AL REGARDING ARTICLE, “ELEVATED LP(A) (LIPOPROTEIN[A]) LEVELS INCREASE RISK OF 30-DAY MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS FOLLOWING CAROTID ENDARTERECTOMY” ArticleWaissi F., De Kleijn D.P.V., Kroon J.Stroke: a Journal of Cerebral Circulation. 2021. С. E66-E67
